Blue Trust’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Blue Trust's ASND Position: Q3 2026 in Review
Blue Trust sold out of Ascendis Pharma A/S (ASND) in Q3 2026, closing a stake of 170 shares — an estimated $45.3K sold.
Blue Trust first reported a position in ASND in Q3 2022 and held it in 11 quarters. The position peaked at $69.7K in Q4 2025. 254 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Blue Trust reported no remaining Ascendis Pharma A/S position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 170 Ascendis Pharma A/S shares in Q3 2026, an estimated $45.3K.
- Blue Trust first reported a position in Ascendis Pharma A/S in Q3 2022 and held it in 11 quarters.
- Blue Trust's Ascendis Pharma A/S position peaked at $69.7K in Q4 2025.
- 254 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.